Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 11
2003 18
2004 14
2005 12
2006 8
2007 16
2008 8
2009 7
2010 13
2011 11
2012 10
2013 13
2014 10
2015 7
2016 8
2017 11
2018 9
2019 9
2020 13
2021 11
2022 3
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Results by year

Filters applied: . Clear all
Page 1
Hypertriglyceridaemia: an update.
Wierzbicki AS, Kim EJ, Esan O, Ramachandran R. Wierzbicki AS, et al. J Clin Pathol. 2022 Dec;75(12):798-806. doi: 10.1136/jclinpath-2021-207719. Epub 2022 Jun 16. J Clin Pathol. 2022. PMID: 35710321 Review.
Familial hypercholesterolaemia.
Defesche JC, Gidding SS, Harada-Shiba M, Hegele RA, Santos RD, Wierzbicki AS. Defesche JC, et al. Among authors: wierzbicki as. Nat Rev Dis Primers. 2017 Dec 7;3:17093. doi: 10.1038/nrdp.2017.93. Nat Rev Dis Primers. 2017. PMID: 29219151 Review.
Lipidomics in diabetes.
Kim EJ, Ramachandran R, Wierzbicki AS. Kim EJ, et al. Among authors: wierzbicki as. Curr Opin Endocrinol Diabetes Obes. 2022 Apr 1;29(2):124-130. doi: 10.1097/MED.0000000000000704. Curr Opin Endocrinol Diabetes Obes. 2022. PMID: 34954721 Review.
Triglycerides and cardiovascular disease.
Esan O, Wierzbicki AS. Esan O, et al. Among authors: wierzbicki as. Curr Opin Cardiol. 2021 Jul 1;36(4):469-477. doi: 10.1097/HCO.0000000000000862. Curr Opin Cardiol. 2021. PMID: 33797418 Review.
Lipid-lowering agents.
Ewang-Emukowhate M, Wierzbicki AS. Ewang-Emukowhate M, et al. Among authors: wierzbicki as. J Cardiovasc Pharmacol Ther. 2013 Sep;18(5):401-11. doi: 10.1177/1074248413492906. Epub 2013 Jun 27. J Cardiovasc Pharmacol Ther. 2013. PMID: 23811423 Review.
SPRINT: Running into trouble?
Wierzbicki AS. Wierzbicki AS. Int J Clin Pract. 2020 Mar;74(3):e13468. doi: 10.1111/ijcp.13468. Int J Clin Pract. 2020. PMID: 32100458 No abstract available.
Editorial: The year in hyperlipidaemia.
Wierzbicki AS, Mikhailidis DP. Wierzbicki AS, et al. Curr Opin Cardiol. 2021 Jul 1;36(4):461. doi: 10.1097/HCO.0000000000000869. Curr Opin Cardiol. 2021. PMID: 34009806 No abstract available.
Radiotherapy, chemotherapy and atherosclerosis.
Min SS, Wierzbicki AS. Min SS, et al. Among authors: wierzbicki as. Curr Opin Cardiol. 2017 Jul;32(4):441-447. doi: 10.1097/HCO.0000000000000404. Curr Opin Cardiol. 2017. PMID: 28306672 Review.
Investigating raised creatine kinase.
Kim EJ, Wierzbicki AS. Kim EJ, et al. Among authors: wierzbicki as. BMJ. 2021 Jun 23;373:n1486. doi: 10.1136/bmj.n1486. BMJ. 2021. PMID: 34162592 Review. No abstract available.
Copper:caeruloplasmin ratio.
Twomey PJ, Viljoen A, House IM, Reynolds TM, Wierzbicki AS. Twomey PJ, et al. Among authors: wierzbicki as. J Clin Pathol. 2007 Apr;60(4):441-2. doi: 10.1136/jcp.2006.041756. J Clin Pathol. 2007. PMID: 17405985 Free PMC article.
210 results